YY2/BUB3 Axis promotes SAC Hyperactivation and Inhibits Colorectal Cancer Progression via Regulating Chromosomal Instability
Advanced Science · 2024-07 · 11 (26)
DOI: 10.1002/advs.202308690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 29.04.2024. Verfasst von Rendy Hosea und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing, 400045, P…. Hauptthemen laut MEDLINE: Chromosomal Instability, Colorectal Neoplasms, Disease Progression. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Chongqing, Natural Science Foundation of Chongqing Municipality.
Abstract (Originalsprache)
Spindle assembly checkpoint (SAC) is a crucial safeguard mechanism of mitosis fidelity that ensures equal division of duplicated chromosomes to the two progeny cells. Impaired SAC can lead to chromosomal instability (CIN), a well‐recognized hallmark of cancer that facilitates tumor progression; paradoxically, high CIN levels are associated with better therapeutic response and prognosis. However, the mechanism by which CIN determines tumor cell survival and therapeutic response remains poorly understood. Here, using a cross‐omics approach, YY2 is identified as a mitotic regulator that promotes SAC activity by activating the transcription of budding uninhibited by benzimidazole 3 ( BUB3 ), a component of SAC. While both conditions induce CIN, a defect in YY2/SAC activity enhances mitosis and tumor growth. Meanwhile, hyperactivation of SAC mediated by YY2/BUB3 triggers a delay in mitosis and suppresses growth. Furthermore, it is revealed that YY2/BUB3‐mediated excessive CIN causes higher cell death rates and drug sensitivity, whereas residual tumor cells that survived DNA damage‐based therapy have moderate CIN and increased drug resistance. These results provide insights into the role of SAC activity and CIN levels in influencing tumor cell survival and drug response, as well as suggest a novel anti‐tumor therapeutic strategy that combines SAC activity modulators and DNA‐damage agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing, 400045, P. R. China.
- The 111 Project Laboratory of Biomechanics and Tissue Repair, College of Bioengineering, Chongqing University, Chongqing, 400044, P. R. China.
- Department of Gastrointestinal Surgery, Chongqing University Cancer Hospital, Chongqing University, Chongqing, 400030, P. R. China.
- Life Science Innovation, School of Integrative and Global Majors, University of Tsukuba, Tsukuba, Ibaraki, 305-0006, Japan.
- Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing University, Chongqing, 400030, P. R. China.
ORCID-Profile: Rendy Hosea, Shourong Wu, Vivi Kasim
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Chongqing
- Natural Science Foundation of Chongqing Municipality
Zitieren
APA
Hosea, R., Duan, W., Meliala, I. T. S., Li, W., Wei, M., Hillary, S., Zhao, H., Miyagishi, M., Wu, S., & Kasim, V. (2024). YY2/BUB3 Axis promotes SAC Hyperactivation and Inhibits Colorectal Cancer Progression via Regulating Chromosomal Instability. Advanced Science, 11(26). https://doi.org/10.1002/advs.202308690
Vancouver
Hosea R, Duan W, Meliala ITS, Li W, Wei M, Hillary S, et al. YY2/BUB3 Axis promotes SAC Hyperactivation and Inhibits Colorectal Cancer Progression via Regulating Chromosomal Instability. Advanced Science. 2024;11(26). doi:10.1002/advs.202308690
BibTeX
@article{Hosea2024,
author = {Hosea, Rendy and Duan, Wei and Meliala, Ian Timothy Sembiring and Li, Wenfang and Wei, Mankun and Hillary, Sharon and Zhao, Hezhao and Miyagishi, Makoto and Wu, Shourong and Kasim, Vivi},
title = {YY2/BUB3 Axis promotes SAC Hyperactivation and Inhibits Colorectal Cancer Progression via Regulating Chromosomal Instability},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {26},
doi = {10.1002/advs.202308690}
}
EUVIMED